ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000708.1|Lividomycin_1 # 1 # 2079 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000708.1|Lividomycin_1 	1	2079	+	Loose	1650	27.7202	Streptococcus agalactiae mprF	31.88	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GATCCGCCGGGCACCGTGACCTCCTTCCTGTACCGCTGCGCCGCGCCGCTGCGGACGCATCCGGGCTGGGCGCAACGGCGGCAGGCGCTGGCCGACGCGGGCCGTCTCTCCCGGATCAGCCCCCTGGAGATGTTCCTCACCGGCGCCTCCGCGTCGCTGCTGTACCACTCGGTCGGTACGCTCACCTTTCTCGGTTCCGGTACGGGCCTGTGGCTCTCGGCCATGCTGGTGGCCCCTACGGTCTGCGTCGCCCTGGGTCTGCCGATCGTGCGGGCGGCGCGCACTCCGGGCGGGCGCACCGCCTCCGGCGCGGTCGCCGGCCTCTGGCTGGGCTGCGGTCTGCTCGTCGGCGAGTTCGTGGGCAGCGGCCGGTACCGGGTCGACTGGTTCCCGGCGCGGCCCCAGTACCTGCTGGCGTTGCTGTTCATCGCGGCCGTGCCCGCGGTGTGGTGGTCGCAGACCCTGCGCCTGTCCCTCGGCCTGCGGGGACGGGGGTGGCGCCGGGCGGCGGTGGTGCTCTGCGCGCTGGTGACGACGGCGGTGCTGTGGTGCGGGCTGTGGTGGTGGCAGCTGGGGGGTCAGCGGATGGCCCTGGGAGGCGCGGATCTGGGTCTGGGAGAGGTCAACGACACCTTGGCGCACGCCGTCCCGGGTTTCGCACACAAATATGACATGGACATGTCTGTATACTCCCTCGGTCTGGCGCTGATCACGCCGCTGCACAAGACGGAGCTCGCCGGTGCCACCGCGGTCCTGATGTGGCTCGTGCCGCTGGTCCTCCTGCTCCTGCAACGTGCGGTCGCGGGCGTGCGGATGCGCCGGACCCTGGGCGCCGGTCTCGCGGGCGGGCTCCTGTCCTGGGCGGGGCTGGCCCTCGCGTCGTACGCGATGTACGTCCAGCGGCCGGGTACCGCCAAAGAGCGCGTGGGCCCCGTCCTGGTCATCCATATATGGTGGGCGATCGCGGCGGTCATGGCCGCGTGTCTGCTGACCGCCGCGCTGGTGGCGGCCTTTTCCCGGCGGTACGGGCTGCTGCGGGCGCTCGTCGCCGCCCAGGTCGCCCAACTGACGGCGTACGCCGGGGTGTTCCTCCTGTACTCCGCCGATGGCTGCCTGGGGCCGCTGAACCCGGTGTTCGACACCTGCCAGTGGCATCCCGCCAACGGTGTGCACGTCGACGACGGGGTCATCACGCTCACCTTGATCAGCACCGTACTCGGGTCGGGCTGTGCGGCACTGATGGGCGCGGGCGCGGCGGGGTTGGTCCGCCGGTTGCGGGGGCGGCGGAGGGGGAGTCTACCGGCGGCGGCCCCGGTCCCGGCCTCGACTCCGGCTCTGGTGCCGACTTCGGTCCCGTCTGAGGCTCCCGTACCGCCATCGGCCCCCGTGCCGGCTGCTCCGGTTCGTCGGCGCCCGCTGCTCCCGGTGATCGTCGGCGTGGTCACGGTCCTGGCGCTCGGCGGGCCCGCTGTGGTGCTGGCCGCCGCCGTGACGACCTCGCCGGCCCCTTCGCCGGTGGCGTTCCGGCCCCGGCAGGGCGCGGCCGGGGCGGACATGAAGGAGAAGGCGCCGGACGAGGGGGAGGTGGCCGGGAAGCCGGGGCGTGGCTCGTCGGCGGCACCGTCTCCCCGGCTGCGCGCGTGGCAGACCTGGGCCTGGATGGACGGTGGCGGGGCCCGGCACATGCAACAGATCAACCGCGCCGTACTGGCCCTGAACTCACAGATCGTCAAGACCGCCGCCCAGAAGCGGGACGCGGAGGGAAAGGTCTACGCGGACGACAAGGCGTTCCATCGGCTGTGCGCCGTCTTGGAGAAGGAAGTCGACGCGACCCTGGAGTATTTCCCCGTACCCGCCCAGAACCTGGACGCCGCGTGGTCGGACGCATTGCGGCAGCTGCGCGGCGGGGCCCGGAACTGCCAGACGGTGACGATCCCGCCCAAGGGCGGGCCGCACCGGACGGAGTCGGAGCGCGGGCGGCTTTTCACCGCCTCCCTCCGCGAGGTCAAGAACGCGATGCTCCTCGTCGGCAACGCGTATCGGAGTATTTACCAGGCGGCCGACTACAAAGGGAAGTGA	DPPGTVTSFLYRCAAPLRTHPGWAQRRQALADAGRLSRISPLEMFLTGASASLLYHSVGTLTFLGSGTGLWLSAMLVAPTVCVALGLPIVRAARTPGGRTASGAVAGLWLGCGLLVGEFVGSGRYRVDWFPARPQYLLALLFIAAVPAVWWSQTLRLSLGLRGRGWRRAAVVLCALVTTAVLWCGLWWWQLGGQRMALGGADLGLGEVNDTLAHAVPGFAHKYDMDMSVYSLGLALITPLHKTELAGATAVLMWLVPLVLLLLQRAVAGVRMRRTLGAGLAGGLLSWAGLALASYAMYVQRPGTAKERVGPVLVIHIWWAIAAVMAACLLTAALVAAFSRRYGLLRALVAAQVAQLTAYAGVFLLYSADGCLGPLNPVFDTCQWHPANGVHVDDGVITLTLISTVLGSGCAALMGAGAAGLVRRLRGRRRGSLPAAAPVPASTPALVPTSVPSEAPVPPSAPVPAAPVRRRPLLPVIVGVVTVLALGGPAVVLAAAVTTSPAPSPVAFRPRQGAAGADMKEKAPDEGEVAGKPGRGSSAAPSPRLRAWQTWAWMDGGGARHMQQINRAVLALNSQIVKTAAQKRDAEGKVYADDKAFHRLCAVLEKEVDATLEYFPVPAQNLDAAWSDALRQLRGGARNCQTVTIPPKGGPHRTESERGRLFTASLREVKNAMLLVGNAYRSIYQAADYKGK	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	81.70	gnl|BL_ORD_ID|2059|hsp_num:0	2283			1641	1848	defensin
BGC0000708.1|Lividomycin_2 # 2169 # 2615 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.631	BGC0000708.1|Lividomycin_2 	2169	2615	-	Loose	600	24.6386	MSI-1	35.48	3003718	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI beta-lactamase	GTGGTGGGGAGTTCCGCGCCCGTGGTTTCCGAGTGGCGCGGCCGAATACCGATGACAGGAGGGGTTATGAAGTGGACTAAGGGGATGGCGACGGTTGCCGCCACGGTGATGGCGGCCGGAACCCTGACATTCGTGGGAGCGGGGAGCGCCGAGGCCGCTTCCTCCTGCCCCGGGAAGCGGGTCAAGCGGGTCAACTTCGACACCGGCTGGACCGACCTGTATTCCAGCAAGAACTACAACTGCGCCATCACCCACAACCGCAAGCCGGGGGTGAAGTACTACATGGGTGCCTACATCCAGGTGATCGGCGGCACCAAGAAGCAGGACTACGGCTACTACACGAAGCACGCGGGCCCGGTGAAGGTCCTCACCAAGGGCGCCTGCATCAACTTCGGTGGCCGGGTGGGTAATACGGGAGACGGCAAGAATTACCACTGCGGCAAGTAG	MVGSSAPVVSEWRGRIPMTGGVMKWTKGMATVAATVMAAGTLTFVGAGSAEAASSCPGKRVKRVNFDTGWTDLYSSKNYNCAITHNRKPGVKYYMGAYIQVIGGTKKQDYGYYTKHAGPVKVLTKGACINFGGRVGNTGDGKNYHCGK	MGARSCSRAWCCSRATRSAPPGRRSGRLSCARCRRPSTGCNPSSTPPITGDIMKHIRLACVAAGLVAAASSVSAIGADWNAPQEPFALFGNSYYVGPHGVASVLITSNQGHILIDGGSDKSPPQIAARIRQLGFKPEDIRFILVSHEHIDHAGGVAELQRLSNAEVLAGAAAVPVLHSGEAGRNDPQYGGLPKMAPVARVRAVRDGEVVKLGPLAVTMHATPGHTQGGASWTWQSNEGGRTANMVYADSLTAFGSGGFRYSGDARYPSARADVERSIAKVAALPCDILVSAHPEVSELWTRYERRAAQGNAAFIDAGACKAYAVKARVKLQEQLARETAKP	43.40	gnl|BL_ORD_ID|2030|hsp_num:0	2233			138	231	
BGC0000708.1|Lividomycin_3 # 2775 # 3764 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000708.1|Lividomycin_3 	2775	3764	+	Loose	650	76.6406	tetA(58)	31.51	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAAGGTCGGCGAAGAAAACTCCCGGGCCGCGCGTCCCCGCGGCCACACCCTCTCCGCCACGGATGTCACCGTGGCGTACGACGGTGTCGATGTCGTGCACGAGGCGTTCCTGGAGCTGCTGCCCGGGCAGGTGACCGTACTGGTCGGGCCGAACGGCAGCGGCAAGTCCACGCTGCTCCGGGCCGTGGCGCGATTGCAGCGGGCGCGGAGCGCGGCGCTGGACCTCGACTGGGGAACGGACGGTTTCGCGCTGACGCCCCGTGAGTTCTCGCGGCAGGTGGCGCTGCTGCCCCAGGGGAGGCCCACCCCCAGCGGGCTGACCGTACGGGACGTCGTCGAGTTCGGACGGTATCCGTACCGGGGGCGCTGGGGCCGGGCCGATCCGGGAGGGCGTGCCGCGGTGGAGCGGGCGCTCGGTATGACCGGGGTCGCCGAACTGGCCGAGCGGGGTGTCGAGCACCTCTCCGGTGGCCAGCTGCAACGGGTGTGGCTCGCCGGGTGCCTCGCGCAGGAGACCGGCGTCCTGCTGCTGGACGAGCCGACGACCTACCTCGACCTGCGCTATCAGGTGGAACTGCTGGATCTGATACGGGACTTGGCGGACGACCACGGGATCGCTGTCGGCGTGGTGCTGCACGACCTGGACCAGGCGGCGGCCGTCGCCGACCGCGTCGTGCTGCTCCGGGCGGGGCGGGTGGTCGCTGACGGCGGGCCCGAGGACGTGTTCACCGCGGAGCGGCTCACGGACACGTACGGCATCCGGATCGAGGTCTCCACCGATCCGCTGACGGGACGGCTGCGCACCCGCGCGATCGGCCGGCACCACACACGCCGGACACCGGACGGCCCCGCGACGCGGAGCGACCACCCGGCACCGGACGGCTCCGCGACGCAGGACGGCCACCCGGCCCAAGACGACCACACGCCGCAGGATCGCGAGCAGAACGCGCGCGACGCGCACAGGGAAAGGCTCCGTACCACCTCATGA	MKVGEENSRAARPRGHTLSATDVTVAYDGVDVVHEAFLELLPGQVTVLVGPNGSGKSTLLRAVARLQRARSAALDLDWGTDGFALTPREFSRQVALLPQGRPTPSGLTVRDVVEFGRYPYRGRWGRADPGGRAAVERALGMTGVAELAERGVEHLSGGQLQRVWLAGCLAQETGVLLLDEPTTYLDLRYQVELLDLIRDLADDHGIAVGVVLHDLDQAAAVADRVVLLRAGRVVADGGPEDVFTAERLTDTYGIRIEVSTDPLTGRLRTRAIGRHHTRRTPDGPATRSDHPAPDGSATQDGHPAQDDHTPQDREQNARDAHRERLRTTS	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	95.92	gnl|BL_ORD_ID|2243|hsp_num:0	2517			93	705	tetracycline
BGC0000708.1|Lividomycin_6 # 7451 # 8458 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GCAC;rbs_spacer=13bp;gc_cont=0.721	BGC0000708.1|Lividomycin_6 	7451	8458	+	Loose	400	31.187	salD	23.48	3007028	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGTTCGAAGCTCCCGAGCGAGCCGTGCTCATCCAGCGCGACCTGCCGGAGCCGGCCCCGGGAGAGGCGCTGGTGCGCCTCGCGTACAACTCGGTCTGCGGCAGCGACCTTTCCTTCTACAAGGGGGTCTGGCACGGCTCCACCTACCCCGTCGTACCGGGGCACGAGTGGAGCGGCACCGTGGTGGACGTCAACGGGGCCGACAGCGGGCTGGTGGGCGTCGACGTCGTCGGTGACCTCACCTGTTCCTGCGGAACCTGCCGGCACTGCGCGGAGGGCAAGCCCACGCTCTGCGGTGACCTCCAGGAACTCGGGTTCACCCGGGACGGCGCGTGCGCCGAGTACATGACCATTCCGGCCGCCAACCTGCACCGGCTGCCCCCGGGGACGTCGCTGCGCGCGGCGTGCCAGGTCGAACCGCTCGCCGTGGCGCTCAACGCCGTGGACCGGCTGGCCGTCGTCCCCGGCGAGAAGGTGGCCATCACCGGCGCCGGAGGCATCGGCCTGCTGCTCGCCCTGGCCGTCCGGCAGCGCGGGGGAGAGGTTACCGCGTTCGCCGAGCCTGTCGCCGAGCGCCGGGAGGCGGCTGCCGCCCTGGGCGTGTCCGCCACCGTCGGGGGCGCGCCGGGCGACCTCGTCGCCCTCGTCGAGAAGCACCCGGAACTGCGGCCCGACGTCGTCCTGGAGGCGTCCGGCTATCCATCGGCCGTACAGGAGGCCATCGAGGCTGTCCGCTCTGGCGGACGGGTGGGGCTGATCGGTTACCGCGTCGAAGAAGTCGGGCCGATGGCGCCCCAGCACATCGTCATCAAGATGCTGACGCTCCAGGCGTCCATGGGGCCCGGCACCCGGTTCGGCGAGGCGATCGGACTGCTGTCCTCGGGCGCCGTCGACGTGGACGCCCTGCTCAGCCACGAGTTCGCCCTGGAGGACCACGCCAGGGCCCTGGACGTGGCCCTGCGCCGCGCCGACGGCAACACCCGCTCGTTCTTCAACCTCCGCACTTGA	MFEAPERAVLIQRDLPEPAPGEALVRLAYNSVCGSDLSFYKGVWHGSTYPVVPGHEWSGTVVDVNGADSGLVGVDVVGDLTCSCGTCRHCAEGKPTLCGDLQELGFTRDGACAEYMTIPAANLHRLPPGTSLRAACQVEPLAVALNAVDRLAVVPGEKVAITGAGGIGLLLALAVRQRGGEVTAFAEPVAERREAAAALGVSATVGGAPGDLVALVEKHPELRPDVVLEASGYPSAVQEAIEAVRSGGRVGLIGYRVEEVGPMAPQHIVIKMLTLQASMGPGTRFGEAIGLLSSGAVDVDALLSHEFALEDHARALDVALRRADGNTRSFFNLRT	MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN	61.58	gnl|BL_ORD_ID|4727|hsp_num:0	5739			63	390	lincomycin; virginiamycin M1; tiamulin; retapamulin
BGC0000708.1|Lividomycin_7 # 8596 # 9813 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=ACGCA;rbs_spacer=14bp;gc_cont=0.737	BGC0000708.1|Lividomycin_7 	8596	9813	+	Loose	900	30.4166	QepA1	42.42	3000448	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTGGCCCCGGCCCGCGGCCGGCGCGGCAGAGGCGGTGCAGCAGGTGCTCTCCTCGGGCCGCTGGTCCATCAGCGGGCCCTACCGGGGCGCCGCGTCCCAAGAGCGGCGCTTCGCCCGCGCGTTCGCCGAGTACAACGGCGTGGCCCACTGCGTCCCCGCCGCCAGTGGCACCGCCAGCCTGATGCTGGCCCTGGAGGCGTGCGGCGTCGGCGCGGGTGACGAGGTCATCGTGCCCGGGCTGTCCTGGGTGGCGTCCGGCTCCACCGTCCTCGGCGTCAACGCCGTACCCGTCTTCTGCGACGTGGACCCCCGCACCCTGTGCCTGGACCCGGAGGCCGTCGAGGCCGCCGTCACCGAGCGCACCAAGGCGATCGTCGTCGTCCACCTCTACTCGGCGGTCGCCGACATGGACGCCCTCACCGCCCTCGCCGAGCGCCACTCGCTGCCGCTGATCGAGGACTGCGCCCAGGCGCACGGCGCCGCGTACCGCGGGGTCAAGGTCGGCGCGCTCGCCACCGCCGGAACCTTCAGTATGCAGCACAGCAAGATGCTCACCAGCGGCGAGGGCGGCGCGGTCATCACCCGGGACGCCGACTTCGCCCGCCGGGTGGAACACCTGCGCGCGGACGGCCGCGTCCTCGCCGGACAGCGGCCGGGGCCCGGCGAGATGGAGCTGGTCGAGACCGGTGAGCTGATGGGCAACAACCGCTGCCTGTCGGAGTTCCAGGCGGCCCTGCTGACCGAACAGCTCAAGGATCTGGACGCCCAGCACGCGATCCGCCGCCGCAACGCCGCCCTCCTCGACGGCCTGCTCCGTGAGTCCGGTTACGTCCCCCAGGAGACCTCCGAGGGCACCAGCACCCGCACCCACTACACCTACGCCGTCCGGCTGCCCGAGGGCCGGCTCACCCACGTGGGACTCGCCACTGTGGCCAGGGCGCTCAGCGCCGAACTGGGCTGCACCGTGGCACCGTCGTACGCGCCGATCACCCGCAACCGGCTCTACGACCCGGCCAGCCGCCGGCGCTTCGCGCTCGGTGTGGAGCACCAGGCCCTGACCGACCCCAAGCGCTTCGAACTGCCGGTGGCCGAGGACGCCGCCCGGCGCGTCCTCACCCTCCACCACGCCGCCCTGCTCGGTGCCGAGGACGACATGCGCGACATCGCGGCGGCGTTCGGCAAGGTCCTGCGGCACGGCGCCGACCTGACCGCATGA	MWPRPAAGAAEAVQQVLSSGRWSISGPYRGAASQERRFARAFAEYNGVAHCVPAASGTASLMLALEACGVGAGDEVIVPGLSWVASGSTVLGVNAVPVFCDVDPRTLCLDPEAVEAAVTERTKAIVVVHLYSAVADMDALTALAERHSLPLIEDCAQAHGAAYRGVKVGALATAGTFSMQHSKMLTSGEGGAVITRDADFARRVEHLRADGRVLAGQRPGPGEMELVETGELMGNNRCLSEFQAALLTEQLKDLDAQHAIRRRNAALLDGLLRESGYVPQETSEGTSTRTHYTYAVRLPEGRLTHVGLATVARALSAELGCTVAPSYAPITRNRLYDPASRRRFALGVEHQALTDPKRFELPVAEDAARRVLTLHHAALLGAEDDMRDIAAAFGKVLRHGADLTA	MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLWILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLGLAGATIAPSTMALVRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFWLNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGEGLASMAALLAGLAVGALFLRRQGHIAYPLLDLRLFAHALFRAALAAYALAALAMFGVYIFMTQYLQLVLGLSPLQAGLATLPCSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQGLWWLVPATIVKGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGSVGLVVYRQALTSAALPGLPADALQTAGASLGGAVHLADTLPAWQGAALLAAARAGFTDALQATAWAGAVLVLVAAGLVARLLRKRPALASG	79.26	gnl|BL_ORD_ID|1199|hsp_num:0	1206			372	468	ciprofloxacin; norfloxacin
BGC0000708.1|Lividomycin_8 # 9810 # 11024 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0000708.1|Lividomycin_8 	9810	11024	+	Loose	700	26.5646	PDC-379	33.85	3006749	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGAGACCGCAGCCCGCTCCCGCGACCGTCCCGCGATCCGCCGCAGAAATCGGGGTGAACATGCACGTCACGGCCATCACCATGGAAGACGCGAACTTTCCCTACCGGCTCGGCACCGACTGTGCCGAAGAGCTCGTCGCCCGGCTGGGCGTGCGCGCCGCCAGCCGCTACCTCGTGGTGTGCGACACCACCGTGGCCGCGCTCTACGGACACGACCTGGTGGCCCGCCTGGAGAAGGACGCCGGCCCGGCCGTCCTGCTCACCCACCAGGTGGGCGAGGTGCACAAGGACGTCACCACCGTCGGCGCGCTGGCCGAACAGGCCCTGGGCGCGGGCGCCGACCGGCGCAGCGTCGTCGTGGCCCTGGGCGGCGGCATCACCGGGAACATCGCCGGGCTGCTGGCCGCGCTGCTCTTCCGGGGCATCACGCTGGTGCACGTGCCCACCACCGTCGTCGCCATGCTGGACTCCGTGCTCTCGCTGAAGCAGGCGGTCAACGCGAGTTTCGGCAAGAACCTCGTCGGCACCTTCTACCAGCCCGCCGAGGTCCTCGCCGACACGGCGATGCTGCGCACCCTGCCCGAACGGGAAGTCCGCTCCGGCATGGGCGAGGTGGTCAAGAACGCCCTCGCCGTCCGCCCCGCCATGGCCGACCGGCTCGCCGGACTCCTGCGCCCCGACGCACGGTACGACGACGACGCGCTGCGCTGGATCATCGCCGAGAGCGTCGCCGCCAAGGCCGATGTGACCGGCGCCGACAAGCACGAGCGCGGGGACGGCCTGGTCCTGGAGTACGGGCACACCGCCGGCCACGCCATCGAGCACGCCGCCCGCGGCGCGGTCGCCCACGGGGCCGGCGTCGCCGTCGGCATGGTGATCGCCGCCGAGGTCTCCCACCGGCTCGGCCACGCCTCCGCCTCCTTCGTCGCCCGGCACCGCGAACTGATCAGCAAGGCGGGCCTGGAGGACACCGTGCCGGCGTGTGTGCGCACCGACGACGTCAAGAACTGGCTGACCTACGACAACAAGCGCGGCTACCTGGACTGCGCGGCCGACACCACCCCCATGGTGCTGCTCGCCGGCCCCGGCCGGCCGCTGCGCACCGGCGGGATGCCCCTGGTGCCCGTACCGCTCGCGGTGCTCAACGAGACCGTGGACGCCCTGGCCGCCCCCGGCCGTGCCGGCACGGACCACCGGACGGCGGTCCCCGTCTGA	MRPQPAPATVPRSAAEIGVNMHVTAITMEDANFPYRLGTDCAEELVARLGVRAASRYLVVCDTTVAALYGHDLVARLEKDAGPAVLLTHQVGEVHKDVTTVGALAEQALGAGADRRSVVVALGGGITGNIAGLLAALLFRGITLVHVPTTVVAMLDSVLSLKQAVNASFGKNLVGTFYQPAEVLADTAMLRTLPEREVRSGMGEVVKNALAVRPAMADRLAGLLRPDARYDDDALRWIIAESVAAKADVTGADKHERGDGLVLEYGHTAGHAIEHAARGAVAHGAGVAVGMVIAAEVSHRLGHASASFVARHRELISKAGLEDTVPACVRTDDVKNWLTYDNKRGYLDCAADTTPMVLLAGPGRPLRTGGMPLVPVPLAVLNETVDALAAPGRAGTDHRTAVPV	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	103.32	gnl|BL_ORD_ID|4439|hsp_num:0	5509			579	759	
BGC0000708.1|Lividomycin_9 # 11098 # 12348 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.743	BGC0000708.1|Lividomycin_9 	11098	12348	+	Loose	700	50.0618	LpsB	26.59	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGCGCGTGCTGCGGCTGACCCCGTTCTTCCACCACGACCAGGTCGAGGACTGGCCCGCCGAGTACGACGCCGTCGGCGGGATGCAGGTGCAGATCCTGCGCCTGTCGCGGGAACTGGCCGATCGCGGCGTCGACCAGCAGGTCATGACCGTGGGCTTTCCCGGCCTGCCCCGGTGGCGCCGGGACCGGCCCGGCCTGGTGGTGCGGATCACCCGCGCGCCGTTGCCGAGGCTGCGCTCGGAGCTGACCGGGCTGGTCGGCCTCAACCAGGCGTGGCTGGTGGGGGCCTTGGCGGCCTGCGCCCGACTGGGCCGCAGCTGGCGTCCCGACCTCATCCACGTGCACGCCGACGGACAGCTGTGGGCGCTGCTCGCCGGGCCGCTGGCGGCCCGCGTCGTGGGCGCCCCCTACTGTCTGACGCTGCACTGCTCCCGGCTGGCCGTGTACGAGCCGATGTCCAGACTCGACCGGTTCCAGCACCGGCTGGTGCGCGCCGTCGAGCGCCACACCGTACGACGCGCGGCCGGGGTGTCCACCCTGACCGCGCGCACCGCCGACGTCGTCGCCCGCGCGCTGCCCATGGACCGCTCCCTCATCGACGTCGTACCCGACTCCGTGGGGGAGTTCGGCCCGCAGCCCGAAGCCGCCGGCGCCTTCCGCCGGAATCTGGACGTGCCCGAGGGAGCGCCCGTGATCGGTTACGTGGGACGGGTGGCGCACGAGAAGGGCTGGCGCGACTTCGTGGCCATGGCCGCGCGGTGGCGGGACGCGCCCGGAGCCAGGGCGGCCGTGTTCCTGGTGGTGGGCGATGGTCCGCAGGGCGACCGGATGCGCAAGGCCGTCGCCGAAGCGGGCCTGACCGACCGCTTCCGCTTCACCGGCTTCCTGCCGCACGCCGAGATCCCCGCCGTCATGACGGCGCTGAGCGTCCTGGTCATGCCGTCCGCGCACGAGGAACTGGGCGGCAGCGCCATCGAAGCCATGATGTGCGGCACCCCCGTCGCCGGGTACGCCGTGGGCGGTCTGCGGGAGACGGTCGGCGGGGTCACCCCCGGCCTCCTCGTATCGCGCGGCGACGTGGAAGCGCTCACCGGTGCGGTCCGCGACGCCGTACAAGTACCGCAAGGAGTGCGGCAGTTGGTCGACGCGGCCCGGCAGCGCCTGGCGGCCGAGTACGGCAGCGGCGCCGCCACCGACCGGGCGCTGGCGCACTACCGCCGCGTCCTGGGCACGAGGAGGGCCGTACGGTGA	MRVLRLTPFFHHDQVEDWPAEYDAVGGMQVQILRLSRELADRGVDQQVMTVGFPGLPRWRRDRPGLVVRITRAPLPRLRSELTGLVGLNQAWLVGALAACARLGRSWRPDLIHVHADGQLWALLAGPLAARVVGAPYCLTLHCSRLAVYEPMSRLDRFQHRLVRAVERHTVRRAAGVSTLTARTADVVARALPMDRSLIDVVPDSVGEFGPQPEAAGAFRRNLDVPEGAPVIGYVGRVAHEKGWRDFVAMAARWRDAPGARAAVFLVVGDGPQGDRMRKAVAEAGLTDRFRFTGFLPHAEIPAVMTALSVLVMPSAHEELGGSAIEAMMCGTPVAGYAVGGLRETVGGVTPGLLVSRGDVEALTGAVRDAVQVPQGVRQLVDAARQRLAAEYGSGAATDRALAHYRRVLGTRRAVR	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	113.66	gnl|BL_ORD_ID|2781|hsp_num:0	3793			516	1026	colistin A; colistin B; defensin
BGC0000708.1|Lividomycin_10 # 12345 # 14150 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GCAC;rbs_spacer=15bp;gc_cont=0.738	BGC0000708.1|Lividomycin_10 	12345	14150	+	Loose	1190	259.61	novA	32.64	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAAGGGCGCCCGCAACGGACCGCTGTGGCGCTGCCTGCGCTACCTGCGTCCGCACGGCTGGTTCATGGCCGGGGCCTTCGGCGCCGCCCTCGGCTCGATGCTGGCCGGGCTGGCCATGCCGGTGATCCTGCAGCGCCTGATCGACGGGCCCCTCGCCCGGCAGGACATGGGGGCGCTGCCGGGCCTGATCGCCGGGTTCGCGCTGCTCGGCGCCGTCGAGGCGGTCCTGCTGGGTGCCCGCCGGCTGCTGGTCGTACGCCCCGCGACGCATCTGGAGACCACGATGCGCGCCCACCTCTTCCAGCACGTCCAGCGGCTGCCCGCGTCCTTCCACTCGCACTGGAGCTCCGGGCAGCTGCTGTCCAGAACGGTGTCCGACGTCACCGAGATCGGCCGGTTCTTCGCGTTCTCCGCCGTGTACCTGCTGGTCAACGTCGCCGCCCTGGTGGCGGGGCTGGGCGTGCTGGCCTGGCTGTCACCCGTGCTCGCCCTGGTCGTGCTGGTCACCTATCTGCCCATGGTGGCCGCCACCGTCTTCTTCGAACACCGCTTCCGTACGGTGGCCCGGAGCGCCCAGGAGCAGAGCGGCGACCTCACCACCACCGTCGAGGAGTCGGTCGCGGGCATCCGGGTGCTCAAGGCCCTCGGCCGCTGCCCCGAGACCGTACGCCGCTTCACCGCGCAGGCCCGTGCCCTGCGCGGCACGGAACTGCGCAAGATCTCCCTGACCGCGGCCCTGTGGTGGACCGCCACCGCCCTGCCCGAACTGGGCATCGTCGCCCTGATGGGATACGGGGGGTACAGCACGGCCACCGGACACCTCACCCTGGGCGTCCTGATGGCGGCCATCACCGTCGCCACGTACATGCGCTGGCCGGCCGACACCCTGGGCTGGCTGGTCGCCGACGCCAGCACCGCCGCCGCCGCGGCCACCCGCTACTGGCAGGTACGTGACATCCCGCTCGCCGTCAGCGACCCGGCGACCCCGCAGCCCCTGCCCCGCCCCCTGCGCGGCGAACTCCGGCTGGAGAACGTCCACTACCGGCACCCCCAGGGCGCCGACGCGATCCTGCGCGGCATCGACCTCACCGTGCCCCCCGGCACCACCCTCGCCCTCGTCGGCGCCACCGGCTCCGGCAAGAGCACCCTGGTCTCCCTGCTGACGCGCCTGGACGACCCCACCGACGGACGCGTCACCCTCGACGGCACCGACCTGCGCGACCTCACCCTGGACACCCTGCGCTCGGCCGTCACCTGCGCCTTCGACGACCCCGTACTGTTCTCCGGCACCGTCCGGCACAACGTCGCCCTCGGCCTGCCGGACGGCACCCGCGACGACGAGAGCGTCCACGCGGCACTGCGCCTGGCACACGCCGACGGTTTCGTCGCGGCGCTGCCCGAAGGGCTGGACACCCGTATCGGCGAGGAGGGCACCGGCCTGTCCGGCGGCCAGCGCCAACGCCTCGCCCTGGCCCGCGCGGTACTCCCCGGCCCCGCCGTCCTCGTCCTCGACAACGCCCTGTCCGCCCTCGACGTGCACACCGAACGCGAGGTCGAGGCCGCCCTGCGCACCGTGCTGGGCCAGGTCACCACCGTCCTCGTCGCCCACCGCCCGGCCACCCTGCGGCTGGCGGACCGGGTCGCGCTCATCGCCGACGGGCGGGTGGCCGCCACCGGAACCCACGACGAGCTGATGGCCACCCACGCCGCCTACCGCGACCTGCTCGAATCCCCGGTGACCGCCCCCACGGAGACGAACGGCACCCCGCGCCACGGCACCGCACGGAAGGTCCAGGCCCGATGA	MKGARNGPLWRCLRYLRPHGWFMAGAFGAALGSMLAGLAMPVILQRLIDGPLARQDMGALPGLIAGFALLGAVEAVLLGARRLLVVRPATHLETTMRAHLFQHVQRLPASFHSHWSSGQLLSRTVSDVTEIGRFFAFSAVYLLVNVAALVAGLGVLAWLSPVLALVVLVTYLPMVAATVFFEHRFRTVARSAQEQSGDLTTTVEESVAGIRVLKALGRCPETVRRFTAQARALRGTELRKISLTAALWWTATALPELGIVALMGYGGYSTATGHLTLGVLMAAITVATYMRWPADTLGWLVADASTAAAAATRYWQVRDIPLAVSDPATPQPLPRPLRGELRLENVHYRHPQGADAILRGIDLTVPPGTTLALVGATGSGKSTLVSLLTRLDDPTDGRVTLDGTDLRDLTLDTLRSAVTCAFDDPVLFSGTVRHNVALGLPDGTRDDESVHAALRLAHADGFVAALPEGLDTRIGEEGTGLSGGQRQRLALARAVLPGPAVLVLDNALSALDVHTEREVEAALRTVLGQVTTVLVAHRPATLRLADRVALIADGRVAATGTHDELMATHAAYRDLLESPVTAPTETNGTPRHGTARKVQAR	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	97.72	gnl|BL_ORD_ID|1112|hsp_num:0	1210			75	1770	novobiocin
BGC0000708.1|Lividomycin_11 # 14147 # 16012 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=CGCACG;rbs_spacer=15bp;gc_cont=0.727	BGC0000708.1|Lividomycin_11 	14147	16012	+	Loose	1100	289.656	tetB(60)	30.97	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCGACGACACCGCAACGGCCGCCCCCCGGCCGCGGACCGAGGACGCACCCGGCGGGCCGGCGGACACCGACTCCGACCGCCTGCTGCGGGACCGGCGCAACCGCCTGCTGCGCACCTTCCTGCGGCCCGAGAAGCGGCGGCTGGCCCTCGCCGTCGGCCTGGCCCTGCTGGAGAACCTCAGCAGCCTGGTCACCCCGCTCCTGATCGCCGCCGCCATCGACCGCGGCCTGCCTGCCGCCACGGACGGCGACTGGGGCCCGCTGACCACCTACGCCACCCTGGCCCTGACGGCGGGCCTGGCCACCGCCACCCTCAAGTACGGCTTCCTGCGCTACTCCGGTGCCATCGCCCAGAGCCTGCTGTTCCACCTGCGGCACCGCACCTTCGGCCACGCCCTGCGGCTGCCGCTGTCCTTCCACGAGGCGTCCCCCTCGGGCAGTGTCGTCGCCCGCCTGTCCAGCGACGTCGAATCGGTCGAGGACGTCCTGGAGATGGGGCTGGACGGACTGTTCTCCGCCCTGTTCTCCATGGTCGGCATCATCACCGTGATGATCTGGCTGGACCTGCCGATGGCCGCCGTCGTCCTCGCGCTCTTCGTGCCCCTGTATCTGCTGACCCGCTGGTTCCGCCGCCGCTCGCGCGCCGCCTACCGGCGCACCCGGGGCGCGACCGAGCACATCGTGCGGCACACCGGTGAGGCGTACAACGGCATCAAGGCCGTCCAGGCGTTCCGCAAGGAGGACGACAACGCCGCCGAACTACGGCGGCTGGACACCGGATACGCCTCGGCGCGCGCGGCCTCCGGACGCGTCAGCGCCTTCTTCAGCGGCGGCGTCAAACTGATCGGCAACCTCTCGCTCACGCTGCTGATGGCCCTCGGCGCCGTCCGCATCGCCCACGGGCAGATGGAGGCCGGCACCCTGGCCGCGTTCCTGCTCTACGTCCACCGCCTGTACGACCCCATCGACGAACTGGCCTCCTTCGCCAACGCCTTCTCCGCGGCCTCCGCCGGACTGGAACGCATCGGCCTGCTCTTCCACGCCACCGACACCCTCCCGGGACCCGGCCGGCCGGTACCCCTGCCGGCCGTGGCCGCGCCCGGCCGGGTCCGCTTCGAGGACGTGCGCTTCCGCTACGCCCCCGGATCGCCGTACGTCCTGGACGGCGTCAGCCTGGACCTTGCTCCCGGACGGACCGTCGCCCTCGTCGGCACCACCGGCGCCGGGAAGTCCACCCTCGCCAAACTCCTGGCCCGGCTCTACGACCCGACGGACGGCCGGATCACCGTGGACGGAGTGGACCTGCGCGACGTCACCGATCCCGAACTGCGCACCCACATCGCGATGATCCCCCAGGAGCCGTTCCTGTTCTCCGGCACCGTGGCCGACAACATCGCCCTGGGCCGCCCGGACGCCACACCCCAGGAGATCCGCCAGGCGGCACGGGCCGTCGGCGCGCACTCCTTCATCACCGCCCTGCCCGACGGGTACGACACCGACGTACGCAAACGCGGGGCCGGGCTCTCCGCCGGACAGCGCCAACTCGTCGCGCTGGCCCGCACGATGCTCGCCGCACCGCGGGTCCTCATCCTCGACGAGGCCACCTCCAGCATGGACGCCCCCTCCGAACGCGCCGTGCACACCGCCCTCGACCGGGTGCTCACCGGCCGCACCGCACTGATCATCGCGCACAGCCTGACCACGGTCGCCATCGCCGACCGGGTGCTGGTGCTGGAGGACGGCGTCGTCGTCGAGGACGGCCCGCCCGCGGTACTGGCCGCGGGCGAAGGGCCGTTCGCCCGGCTGCACGACAGCTGGCTGTGGGCCACCGACCGGCGCGCCCACCACTCCTCGGACCACTGA	MTDDTATAAPRPRTEDAPGGPADTDSDRLLRDRRNRLLRTFLRPEKRRLALAVGLALLENLSSLVTPLLIAAAIDRGLPAATDGDWGPLTTYATLALTAGLATATLKYGFLRYSGAIAQSLLFHLRHRTFGHALRLPLSFHEASPSGSVVARLSSDVESVEDVLEMGLDGLFSALFSMVGIITVMIWLDLPMAAVVLALFVPLYLLTRWFRRRSRAAYRRTRGATEHIVRHTGEAYNGIKAVQAFRKEDDNAAELRRLDTGYASARAASGRVSAFFSGGVKLIGNLSLTLLMALGAVRIAHGQMEAGTLAAFLLYVHRLYDPIDELASFANAFSAASAGLERIGLLFHATDTLPGPGRPVPLPAVAAPGRVRFEDVRFRYAPGSPYVLDGVSLDLAPGRTVALVGTTGAGKSTLAKLLARLYDPTDGRITVDGVDLRDVTDPELRTHIAMIPQEPFLFSGTVADNIALGRPDATPQEIRQAARAVGAHSFITALPDGYDTDVRKRGAGLSAGQRQLVALARTMLAAPRVLILDEATSSMDAPSERAVHTALDRVLTGRTALIIAHSLTTVAIADRVLVLEDGVVVEDGPPAVLAAGEGPFARLHDSWLWATDRRAHHSSDH	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	107.25	gnl|BL_ORD_ID|2307|hsp_num:0	2646			3	1719	tetracycline
BGC0000708.1|Lividomycin_12 # 16026 # 17666 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0000708.1|Lividomycin_12 	16026	17666	+	Loose	500	26.5646	RCP-1	45.71	3003563	protein homolog model	n/a	n/a	penam	antibiotic inactivation	RCP beta-lactamase	ATGGAGCGCCTGCGGGGACCCTCGCCACTGGAGAACACCACCGCCCGCCACCCGGCACCGCTCGGCCCCGCCCACCGCGACGGCCTCGAACCCGGCACCGCCGACCGCGTGTGGGACGTCTGCGTGATCGGCAGCGGGGCCAGCGGCGCGGTGGCCGCCGACCGCCTGGTCCGCCAGGGCCTGGACGTCCTCATGGTCGAGGAGGGCTTCCGGCTCGCCCCGCACGTCGGCCTGGACGAGGCCGAGTCCCTGAGCCGGCAGGCGCTCGCCCGCGACGGCGAAGGGAACTGGACCGACGAGGGCTGGCCCTGGACCACCTCCAACCTCGGCGGCGGCACCGTGTACTACGGAGGCGCCTCCTTCCGCTACCGGCCCTTCGACTTCGACCCCGGCGAACTCGTCCACACCGACGGCGTGGACGTCCGCTGGCCCTACACCCTCGCCGACCTCGTCCCGTACTACGAGGTCCTCGAACGCCGCCTCGGCGTGTGCGGCGGCGACGCGCCCGGCATCCACCGCGGCAGCCGCCACAGCCGAGGCCCTGCCCACCAGCCCTCCCCGGCCGCCCGCGTGCTGCGCGCGGCCGGCGAGTCCCTCGGCTACCGGCCGTTCCCCACCCCCCTGGCCATCAACCGCGACCCCCACGGGGGCCGCGCGGCCTGCGCACGCGACTCCCTGTGCGTCAGCCACCTGTGCCCCACCGGAGCCAAGGGCGACGTCGTCGCGGTCTTCCTCGCCCCCCTCGCCGCCCACCCCAACTTCGCCCTGCGCACCGGGGTCCGCGCCCTGCGGCTGGAACAGGACCGCTCCGGCGAGGTCGCCGCGGTCCGCTGCCTGGACCGGCAGACGGGCCAGGCACACCGCGTACGCGCCCGCGTCTACGTCGTGGCCTGCAACGCCATCCAGAGCGCCGCCCTGCTGCTGCGCTCCCGTACCCCGTACTCACCCGACGGCGTCGGCAACCACTCCCACCTGGTCGGCCGCGGACTGTGCATGAAGCTCAGCGAATACCTGAGCGGCACGGTGGACGCCGACCCCGCCGTCCTCGCGGACCCCTACACCAACACCGGCCCCTTCTCCACCGTGGCCTTCCTCGACCACTACCTCGACCCCGACTGCCCCGGCGGATTCGGCGGCCTGATCTACGAGTCCAAGCGCGACCAGCGGCACAAACTCGTCCACGACGCCCTGGAACTCAGGATCGAGACGATCCTCGCCGACCACCCCAACCTCGACAACCGCGTGGGACTCTCCACGCACCTCGACGAGGACGGGATGCCGGCCGTGGTCATCGACTACACCCCCGACCCCCGCGACCTGGACCGGCTGCGCTACATGACCGGCCGCTGCGAACGCCTGCTGCGCACCGCCGGCGCCCGCGGCATCCGCAGCCGGAGCACCGGCTTCGCGCAGGGCAGCTCCCATCTGCACGGCACCTGCCGGGCGGGCCACGACCCGGCCCGCTCCGTGGTGGACGCCTGGGGACGGGTCCACTCGGCGGACAACGTCTACATCGTGGACGGCAGCTTCATGCCGTACCCGGGTGGCCTCAACCCCACCCTGACCATCCAGGCCCACGCCCTGCGCACCAGCAGGGCCATCGCCTCCCACCTGGCGGCCGACCGCGCCGCCCATGTGTGA	MERLRGPSPLENTTARHPAPLGPAHRDGLEPGTADRVWDVCVIGSGASGAVAADRLVRQGLDVLMVEEGFRLAPHVGLDEAESLSRQALARDGEGNWTDEGWPWTTSNLGGGTVYYGGASFRYRPFDFDPGELVHTDGVDVRWPYTLADLVPYYEVLERRLGVCGGDAPGIHRGSRHSRGPAHQPSPAARVLRAAGESLGYRPFPTPLAINRDPHGGRAACARDSLCVSHLCPTGAKGDVVAVFLAPLAAHPNFALRTGVRALRLEQDRSGEVAAVRCLDRQTGQAHRVRARVYVVACNAIQSAALLLRSRTPYSPDGVGNHSHLVGRGLCMKLSEYLSGTVDADPAVLADPYTNTGPFSTVAFLDHYLDPDCPGGFGGLIYESKRDQRHKLVHDALELRIETILADHPNLDNRVGLSTHLDEDGMPAVVIDYTPDPRDLDRLRYMTGRCERLLRTAGARGIRSRSTGFAQGSSHLHGTCRAGHDPARSVVDAWGRVHSADNVYIVDGSFMPYPGGLNPTLTIQAHALRTSRAIASHLAADRAAHV	MRFTATVLSRVATGLALGLSMATASLAETPVEALSETVARIEEQLGARVGLSLMETGTGWSWSHREDELFLMNSTVKVPVCGAILARWDAGRLSLSDALPVRKADLVPYAPVTETRVGGNMTLDELCLAAIDMSDNVAANILIGHLGGPEAVTQFFRSVGDPTSRLDRIEPKLNDFASGDERDTTSPAAMSETLRALLLGDVLSPEARGKLAEWMRHGGVTGALLRAEAEDAWLILDKSGSGSHTRNLVAVIQPEGGAPWIATMFISDTDAEFEVRNEALKDLGRAVVAVVRE	186.35	gnl|BL_ORD_ID|895|hsp_num:0	882			261	354	
BGC0000708.1|Lividomycin_13 # 17694 # 18593 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000708.1|Lividomycin_13 	17694	18593	+	Loose	350	26.9498	catB11	36.11	3004660	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGACACCCCTGTCGTCTGGCCGCCCCGCACGCGGCGCATCCGCACCTACCGCAACATCGTCATCGACGGCGCCTGCAACCTGCGCTGCACCTACTGCGAGGTCAAGGCCATCAAGGTCGACCAGGTGGCCACCAACGCGTCCCTGGACAAGATCTTCGAACGGTACGAGCCCGACAACACGCTCTTCCGCGTGGAGTCCAACGGTGAGATCGCCCTCTACCCGAAGATCCTCGACCACCTCCAGCGCCGCGCCGCCGAAGGCTGGCACATCGAGGTGCTGAGCAACGGCACCCGGCTGCCGCGCTGCCTGGAGGGCCGGGAGAATTTGATGTGGGTCTTCTCCGTAGACGGCCACACCGCCCGGATGAACGCCCAGCGCGGACTCTCCCAGGAACAGGTCGACCGCATCGTCGACACCGCCGTCGAACTCGACGCCGAACTCCAGATGGTCTACCACGACCAGACCCTGGAGGAGGTCAACGACTTCATCGACCTGCTGTCCTCCCGCGGCTACAAGGGCCTGCTGCACTTCATGCCCCTGCTGGCCTTCAAGGGACAGCCGCTGACCGTCAACCTGCGCTACGAGGACCTGCACCCCGCCGACTTCCTCGCGCCGCCCGAGTACTTCCGCCGCTGGAACCACATCTTCGAGACCGGCAAGCGCGACGCGGTCTGCGACCAGATCTCCAACGGCTACAACTACTCGGTCTCCGACGACCGCATCCAGATGGTCAAGTGCGACTGCTACTCGGTCCCCAAGCACCTGTACCACGACTTCGGCGACGTGCGGGAGTTCGACAACTGGCCCTGCGGCACCTGCATCGCCAACCAGGAGTTCAACAACTCCCGCCCGCGTATGCAGGTCCCCGAGGGCCGGATACCCCTGCCCCTCGTATGA	MDTPVVWPPRTRRIRTYRNIVIDGACNLRCTYCEVKAIKVDQVATNASLDKIFERYEPDNTLFRVESNGEIALYPKILDHLQRRAAEGWHIEVLSNGTRLPRCLEGRENLMWVFSVDGHTARMNAQRGLSQEQVDRIVDTAVELDAELQMVYHDQTLEEVNDFIDLLSSRGYKGLLHFMPLLAFKGQPLTVNLRYEDLHPADFLAPPEYFRRWNHIFETGKRDAVCDQISNGYNYSVSDDRIQMVKCDCYSVPKHLYHDFGDVREFDNWPCGTCIANQEFNNSRPRMQVPEGRIPLPLV	MKNYFESPFKGKPLVEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIGSFCSIGTGASFIMAGNQGHRYDWVTSFPFFYMNEEPAFSESVDAFQAAGNTVIGSDVWIGSEAMIMPGVKVGHGAVIGSRALVTKDIEPYTIVGGNPAKEIKKRFSEQEISMLLDMKWWDWPLEQIKEAMPLLCSSDIAGLYHFWQRSSA	142.38	gnl|BL_ORD_ID|2201|hsp_num:0	3360			504	612	chloramphenicol
BGC0000708.1|Lividomycin_15 # 19276 # 20349 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=ACCCA;rbs_spacer=15bp;gc_cont=0.749	BGC0000708.1|Lividomycin_15 	19276	20349	+	Loose	500	27.7202	LlmA 23S ribosomal RNA methyltransferase	38.89	3003982	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target alteration	Llm 23S ribosomal RNA methyltransferase	GTGAGCGGACCCGTGGAGCCCGGCCCGCCACCGGCCGCGCCCCGGGCCCTGTTCGAGATCTACGACGAGGGCTTCGCCTGCGACACCTGGGGAGGTGTGGAAACCGCCCTGTGGAGCCTGGCCGAAGGACTGCGCGCCCACGGAGTACAGGCCGACTTCTACCTCTCCTCCCAGGGCGCCGACCTCGAAGCGCTCGCCGACCGGGTGGCCCGGGAAGGGACGGACGCGGTCTTCCCGCTGGTGGAAAGCGCCCTGTTCCGCGGCGACCGATGGCGTCGGCTGCCGGCGCTGCACCGCCGCGTGGCCCGTATCTGGCACGACGTCAGCCATCTGACGTCCGACCTCACCACCCCGCCGCCGTGCCCGGCGCACACCCCCGGCGCGGCACCGGACCCGGAGGCCGGGTGCCCGGCCGCGCCGGCCCACCCGGACGGGCCCATGCGCGAGATCTTCCTGCGCGACCTGCCCTGGACCCGCTGCTTCCCCGACCGCGCGTACATCCCCTGGGCCGCCGACCACCTGTCCGCCGAGGACCTGCGCGACCCCCGCGGGCCCGTCGTCATCCAGCTCGGCAAGACCCCCGTCGAAGACGCCGAACGCTGTCTGACCCGGCTCCTGGCGGCCCGGCTGCCGGTCCGGGTGGTGTTCGCCACCTGGTCCCGGCAGGGCCGGGCCGCCCGGGCACTGGTCCACGAGCGGGCCGCGTCCGGCGCCGCCGTCGAGGTGTTCGACACCTATGACATCCGTACGGACTGGAAGCGGGTGTACGGGGGAGCGCGGCTCTTCGTACTGCCCTCCGTCTTCCACGAGACCTTCAACTTCGCCGCGGCCGAGGCCGTCCAGCTCGGACTGCCCGTCGCGACCCTCGGCGACTGCGGAGCCCTGCCCGGCTTCGCCTCGCTGACCGCCGCCACCGTCGGCGACCTGATGGACCGGGTCGTCACGGAAGGCGCGACGGTACGGCCCCGGCCGCGCTCGCGCACCGGCTGGGACGAGGTCGCCCGGCGCTACGCGCGGCTCATCACCACGACCGGGGCCCGCGCCCGGCACGAGGAGGCGACATGCCGGACCTGA	MSGPVEPGPPPAAPRALFEIYDEGFACDTWGGVETALWSLAEGLRAHGVQADFYLSSQGADLEALADRVAREGTDAVFPLVESALFRGDRWRRLPALHRRVARIWHDVSHLTSDLTTPPPCPAHTPGAAPDPEAGCPAAPAHPDGPMREIFLRDLPWTRCFPDRAYIPWAADHLSAEDLRDPRGPVVIQLGKTPVEDAERCLTRLLAARLPVRVVFATWSRQGRAARALVHERAASGAAVEVFDTYDIRTDWKRVYGGARLFVLPSVFHETFNFAAAEAVQLGLPVATLGDCGALPGFASLTAATVGDLMDRVVTEGATVRPRPRSRTGWDEVARRYARLITTTGARARHEEATCRT	MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSGGGQWDMKKQLPDRWTISYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVLNLFAYTGGATVAAASAGAQVVHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQREQRRGNKYDAIIMDPPSYGRGPSGETWKLEQSLYPFLESCMSIVSDNPLFMLINSYTTGISPTVLNNMLTMTMKPKYGGTISAGEIGLPITRSGMNLPCGILGRWES	124.39	gnl|BL_ORD_ID|2227|hsp_num:0	2519			456	564	clindamycin
BGC0000708.1|Lividomycin_16 # 20337 # 21095 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GCCCG;rbs_spacer=15bp;gc_cont=0.752	BGC0000708.1|Lividomycin_16 	20337	21095	+	Loose	500	26.5646	OXA-118	41.3	3001768	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCGGACCTGATCACCGAACTCCGCGAACACCGCACCCTGTTGATCGCCCCGCACCCGGACGACGTGGCCTACTCCTGCGGCGGCGCGCTCGCGGCCTGCGCCGGAGCCGCACGCGCCGTCCTGCTGACCGTCTTCACCCGCTCCGCGTGGGCGCTGCCCAAGCGGCTGCGCGCGGCGGGCCCGGCGGTGATCAGCGCCCGGCGCCAGGAGGAGGAACTGCGCTACTGCCGCGCCCGGGGGCTGGAGCGCTATGTGCCGCTGGGCCTGGACGACGCGAGCCTGCGCGGCTACGACGACGACACGGAGATGACGGCGGACCCGGCGGCCGATCCGGCACGCGAGCACGTCGCCCGGGTGATCGCGGCGGCCGTCCGCGACCTGCGGCCCGGTCTCGTGCTGGCCCCCGCCGCCGTCGGCGGCCACGTCGACCACCGCCTGGTGCACGACGCCGTACGGGAGTCGGCGCGCGACGGCGTACGGCGGCTCTACTACGAGGACCTGCCCTACGCCGCCCACCAGGAGCCCGCGGACCTGGAGAAGACGCTCACGGTGGAGCGGGGACTCGTCCCCTACGCGACCACCGACGTGGCGCACGTCTTCCAGGACAAGGTGCGCGGCATGTACGTCTACGGCAGTCAGACGGACGAGGAGTGCGTACGCGAAGTGACCCTGCACGCGCGGCGGACGGCCGGGAACGCGCCCGACGGCCGCGCCGAACGGGTGTGGGCACCGGCCCCCGCGGGCCGGGCCCGGTGA	MPDLITELREHRTLLIAPHPDDVAYSCGGALAACAGAARAVLLTVFTRSAWALPKRLRAAGPAVISARRQEEELRYCRARGLERYVPLGLDDASLRGYDDDTEMTADPAADPAREHVARVIAAAVRDLRPGLVLAPAAVGGHVDHRLVHDAVRESARDGVRRLYYEDLPYAAHQEPADLEKTLTVERGLVPYATTDVAHVFQDKVRGMYVYGSQTDEECVREVTLHARRTAGNAPDGRAERVWAPAPAGRAR	MAIRFLTILLSTFFLTSFVHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFGQERAAKRYSPASTFKLPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNSAVWVYELFAKEIGKDKARHYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYRNQLPFQVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTPNRTDDLFKREAIARAILRSIDALPPN	94.74	gnl|BL_ORD_ID|1785|hsp_num:0	1937			72	210	cloxacillin; oxacillin; cefalotin
BGC0000708.1|Lividomycin_17 # 21149 # 23284 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.768	BGC0000708.1|Lividomycin_17 	21149	23284	-	Loose	500	29.261	OXA-641	28.79	3005333	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCTGTTGATCGGAAGTCGGCGCCCCGGACACAGTCATGGCCCGACGGCCGCGAAAGGTACCGGAGAACGAAAGGCCGTGAAACGGGACTTCGGAAACCCGAGCCGAAATCAGCGAGGGCCGGGCGGAGTCGGGAGAGGAGAAGTCGTGCGGACCACCGACGAGCGGTTCACCTACGGAGGCAGCACTCCGGCGATCTTCGGAGCGGACGGCGGCACCCCGCCGCCGGACGGCGGGACCGTGCGGCCGGACGGCGGGACCGTGCGGCCGGACGGCGTCCACGTGCCGCCCGCCTCCCCCGCTCTGCCGCCGCTGCACCGGACGTTCCTGGAGCACACCGTCCGGGACGGCGGCACGGAGGCCCGGTACGCGTGCGCCTGCTTCGTCGAACAGATCCTCGCCGACACCGCCGCGTGCCGGGCCGCCCCGGCGGCGGCCCACACCCTCCTGGACGAGGTGCGGCAGGCGTGCCTGGCCCTGGCGACCGCCGTCGCGACCGGCCCCGGGCAGGAGGTTCCGCACCCCTCGGCCGCCTTCCTCCAGTACGCCATGCTCTCGGCCGTGGCGCAGACCACCGCGCTGTGGCGGGCCGGCGCGGCCCGGGGCGACGCGACGGCCGAGGCGCTGCTGCGGCACGCCACCGACTGGAAGACGCCCGAGTGTTACGCGTACGACCTCGCCGACCTGTCGCCGGTGCACGGCCAGGCCACCGCGTGGCTGCGGGAAACGGCGCCCCGGGGGCCGGTGTTCGTGGTGGGCGTGCGTACGGGCGGCTCCTACCTGGCTCCCCTGTGGGCGGCGGCGGTCGCCGCGCGGGGGTGTCAGGCCGCCGCCTGGACCACGCTGCGGCCGCTGCGCCGGGCGGGGCGCGCCGAGCTGGTACCGGCCGAGACCGACCGGCTGCCGTCGGAGCTGCCGCCGGGGACGACCATCGTCGCCGTGGACGACCAGCCGGACACCGGGAACACCGCCCGCGCCGTGCGCGACGCCCTGATCCGACGCTTCCCGGCCGCCCGCGACATCGTGTTCGCGTCCCCGGGCCGCGTGTACCACCTGGACGACGGCGGGCTGCGGCCCGTGGTGGAGACCTCGCCGGTGCACACCGCGCCGCCCCGGCTGTGGCAGTCGCTCGCCCCCGCCGACGCGGACCGGCTGACGGCCCGCGCCAGGGCGCACGGCATCCTTCCCACCGATGGCACGCGCTATCGGCCCGCCCCCTTCCGGGGCCCGTTCCAGGAGCGCTACGGCCCGTCGGCCGGCTCCGGGCCGAACACGGACGGCGTGCCGGCCGAGCCGGGGCCGCGCCGCATCAGCCCCCGCAACCGGCCGTTCTCGCTCGTCCCGGACGCCGGAGAGGACGGCGCGTACCACTTCCGTTTCGTCGGTACGGGCCCGCACGGCGGGGCGGGTGCCCGAACGCTGGCCGCGCTGGGCGAGTTCCTGCCGCCGGTGCGGCACCACCTCGACGGCTACCTCGTCACGGCGCACGAGCCGGGCCTGCTCCCGCTGGGACACGCGCTGGCCGGGCCGTCCGGGCCGTGGCGCCGCCGGGCCCTGGAGGCCGTGGTCCGCTACTGGCGGGGGCTGGAGGTGCTGGGCGGGCTGGGCGAGGTGGACCGGGCCGTCGTCCATGATCCCAGGGACCGGCTGGACACCGCGCTGCGGCGGCTGCGGGAGCGGCTGTCCGGGCCGCTGCCGGTGGACGGCGCCTGGCTCGACCGGCACCTGCCCCGCCGGGCGGCGCTGGGCGGCATCCACGGCCGCGTGCTGCGGACGTCGCTGCCGTACTCGCACCAGAGCTGGCACTGGCGGGTGAAGGTGCCCGCCGGGGCACACGAGCCGGTGGCCGTGCGGCGGTTCGGGCTGGACTGGGTCTGGGGCGGGGTCGGGTCGCTGGAGTCCGAGATCGCCTCGTTCGTGGTCGAGAACCGGCTGGACGGGGCGTGTCTGGACGAGCTGCGCGCGGCGCTGGCCGACGACCCGCTCCTGGATGCCGCGCTGGAGCTGGCCGGTGAGGCCCTGTGGTGGAACGTGAAGTCGTGGCTGCGGCGCTGTCCCGCGCCGGACGCCGGCGCCGCGCGGCGCATCCGGGAGGACCTGGACGCCATGGCCCGTTACGTGGCGGGCCTGCGCTGA	MLLIGSRRPGHSHGPTAAKGTGERKAVKRDFGNPSRNQRGPGGVGRGEVVRTTDERFTYGGSTPAIFGADGGTPPPDGGTVRPDGGTVRPDGVHVPPASPALPPLHRTFLEHTVRDGGTEARYACACFVEQILADTAACRAAPAAAHTLLDEVRQACLALATAVATGPGQEVPHPSAAFLQYAMLSAVAQTTALWRAGAARGDATAEALLRHATDWKTPECYAYDLADLSPVHGQATAWLRETAPRGPVFVVGVRTGGSYLAPLWAAAVAARGCQAAAWTTLRPLRRAGRAELVPAETDRLPSELPPGTTIVAVDDQPDTGNTARAVRDALIRRFPAARDIVFASPGRVYHLDDGGLRPVVETSPVHTAPPRLWQSLAPADADRLTARARAHGILPTDGTRYRPAPFRGPFQERYGPSAGSGPNTDGVPAEPGPRRISPRNRPFSLVPDAGEDGAYHFRFVGTGPHGGAGARTLAALGEFLPPVRHHLDGYLVTAHEPGLLPLGHALAGPSGPWRRRALEAVVRYWRGLEVLGGLGEVDRAVVHDPRDRLDTALRRLRERLSGPLPVDGAWLDRHLPRRAALGGIHGRVLRTSLPYSHQSWHWRVKVPAGAHEPVAVRRFGLDWVWGGVGSLESEIASFVVENRLDGACLDELRAALADDPLLDAALELAGEALWWNVKSWLRRCPAPDAGAARRIREDLDAMARYVAGLR	MKHIFLVFLILCSNFALAEDKAISAIFSTEGVDGTIILKSLRGDKTITHNDARASRRFASASTFKIFNTLIAVQENVVSLSGTAFRWDGKTHDFPDWNRDQTLESAFKVSCVWCYQEIAKQVGEETYRRYLALARYGALSNVADSTTFWLDGSFTVSAVEQVALLKKIYLRELPFRDDAYDALKRVMLAEQTDSYKLYAKTGWAGRMNPQIGWYVGYVETSDDVWFFAINLTLRSETDLGLRQQITKAVLRAERIIP	276.65	gnl|BL_ORD_ID|3040|hsp_num:0	4065			300	498	cloxacillin; oxacillin; cefalotin
BGC0000708.1|Lividomycin_18 # 23304 # 24554 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000708.1|Lividomycin_18 	23304	24554	+	Loose	575	28.1054	SPU-1	27.54	3006998	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPU beta-lactamase	ATGACGCGAAATTCCTCCACGCTGGCCGAAAAGCCGACCTGCCCCAAGGACGCGGACGGCAATCCCCGGATATTCACCGCGGCGCGCGGTGCCCGGCTGACCGACCGTGCCGGAAAGGAGTGGATCGACTTCGACAACGCCCGGGGCTCGGTCGTCCTGGGCCATGCGGACCCCGAGATCGCGGAGGCGGTCGCCCGCGCCGCCTCCGGCGCGGCCGGCACCGCCACCGGCTGGAGCCCGCTGGTCGACACCGTCGCCGACCGGCTGCTCGCCCTGTGCGGCGGCGAGGTCGTCGGCCTCTTCCGCACCGGCACCTCCGCCGTGCGCGCCGCCGTACTGGCGGTACGCGAATCCGTCGGCCGGCCCCTGGTCCTGAGCTCGGGCTACCACGGATACGACCCCATGTGGTATCCGCCGCACGAGCCGCTGGAGCCCAACGCGGACGGGATCGTCGACTTCTTCTACGACCTCGACCTGCTGGCCGGCCTGCTGCGGGACCGCGACCGGATCGCCGCCGTGGTGATCTCGCCCGACCACATGCACCTGACGCCGGGCTGGTACGCGCGGGCGCGCGCCCTGCTCGCCGACGCCGGAGTCCCGCTGATCGTGGACGAGGTCAAGGTGGGCCTGCGCTACGGCCCGGGGCTGTCCACGGCGGACCTGCTGGACGCCGATGTGTGGGTGGTCGCCAAGGGCATGGCCAACGGCTATCCGACGGCCGCGGTGGGCGGCTCGCGCACCCTGCTCAAGCCGCTGCGCGAAGTGTCCTTCACCTCCTTCTTCGAGCCCACCGTCCTGGCCGCGGCCGAACGCACCCTCGCCCGCGTGGCCACCGGCGCTCCCCAGCGGACCGTGCGCGAGGCGGGGGAGCGCTTCCTCACCCACGCCCGCAAGTCCCTCGCCGGGGCCGGGCTGCCGGTGGAACTGGCCGGTGACGGCTCCTTCTTCCAGTTCGTGGCCGCCACGCGGGAGCTGGAGAAGGCGCTGTGGTGGGCGACGGAGGACGAGGGACTGCTGTTCTACCGGGGCGACAACCAGGCCGTCTCCGCGGCGTTCGGACCGGACGTCCTGGACGACGCCGAGGCCCGCTTCACCCGCGTCTGCGACCGGCTGGCGCCCTACGCCTCGGACGCCCCGGTGAGTGAGGAGGCCCGTTACCTCGCGGCCTGGAACGTCATCGACGGACTGCGCGACGCCGCGCGGGACGACCGGACCACCCGGGAGTGGATCAGCCGTCTCCTGGACGACTGA	MTRNSSTLAEKPTCPKDADGNPRIFTAARGARLTDRAGKEWIDFDNARGSVVLGHADPEIAEAVARAASGAAGTATGWSPLVDTVADRLLALCGGEVVGLFRTGTSAVRAAVLAVRESVGRPLVLSSGYHGYDPMWYPPHEPLEPNADGIVDFFYDLDLLAGLLRDRDRIAAVVISPDHMHLTPGWYARARALLADAGVPLIVDEVKVGLRYGPGLSTADLLDADVWVVAKGMANGYPTAAVGGSRTLLKPLREVSFTSFFEPTVLAAAERTLARVATGAPQRTVREAGERFLTHARKSLAGAGLPVELAGDGSFFQFVAATRELEKALWWATEDEGLLFYRGDNQAVSAAFGPDVLDDAEARFTRVCDRLAPYASDAPVSEEARYLAAWNVIDGLRDAARDDRTTREWISRLLDD	MKKYFSFCLLGIFIFCFSQQNLKRDITKIIQGKNALVAVSVMNSKGKTEVNINGNKKVPMLSVFKFHIALAVLDLVDRGILDLEQNIFVKKSELLENTWSPIRDKYPNGNVNIPLREIIEHTVSQSDNNGCDILLRLIGGVDTVQKFIESKGIKDFAIKYNEEEMNKNGKSIYSNYTTANASSRLLQKFYNGEIISESSRDFLFRIMYETSTGADRLISLLPPDVIVAHKTGTSGIVSGIQAATNDVGIIILPDDEYYTISVFVINSKENTSTNEKIIADISKTVWDYYFQNK	141.98	gnl|BL_ORD_ID|4593|hsp_num:0	5663			633	840	
BGC0000708.1|Lividomycin_19 # 24937 # 26307 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GCAC;rbs_spacer=13bp;gc_cont=0.748	BGC0000708.1|Lividomycin_19 	24937	26307	-	Loose	500	25.7942	TEM-193	30.84	3001053	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	GTGACACGCCCCCGTTCCCCGCACCGCCCCGCCCGCCGCCGGGTCTCCCGCGCCGCCGTCGCCCTCCTCGTCGCGGCGGCCGTCCCCACCCTGACCTCCGCCACCGCCGACGGAACCGGCGGCGGCAGCCCGCGCGCGGCGCGGAACGTGATCCTGCTCATCGGTGACGGCATGGGCGACTCGGAGATCACGCTGGCCCGCGACTACACGGTGGGCGCGGGCGGCCGGCTGAACCTGGACCGCTTCCCCTCGACCGGTACGTACACGACGTACTCGGTCGACAGCCGGGGCCGCCCGGACTACGTCACCGACTCGGCGGCGAGCGCCAGCGCCTGGTCGACCGGGCACAAGACCGTCAACGGCCGGATCTCCAAGTCTCCGGGGACCGACACCGCGCTGCCCACGATCCTCGAACTGGCCCGTGCCAAAGGGCTCGCGACCGGGTCCGTGACCACCGCCGAACTCACCGATGCCACCCCCGCCGCGATGGCCGCCCACGCCACCGACCGCGACTGCCAGGGCCCGGCCGACATGGCGGCCTGCCCGCGCGACACCATCGCCAGGGGCGGCCCCGGCTCGATCGCCGAGCAGTCCGTACGGCTGCGGCCCGACGTACTGCTCGGAGGCGGCCGGCAGCGCTTCGACCAGAAGATCACCCAGGGCCCCTACCGGGGCATGACCGTGACCCAACAGGCCGAGAAGCTCGGCTACCGGGTGGTCACCGACGCCGGAGGACTGCGCACGGCCGCCCCGGGACAGCCCCTCCTCGGACTCTTCGCCCCCGGTGCGATCCCCGTGGAGTGGACGGGCCGCCCCGCGGCGGCAGGCGGCACCGCGCCGCAGCGCTGCGTCACCGCCAACCCGGCGCGCCCGGCCGGAACCCCGTCCCTGGAGCAGCAGACCGCCAAGGCCCTCGAACTGCTGGAGGCCCGGGCGCGGGCGGGTGGCGGCGCGGACCGGGGCTTCTTCCTCCAGGTGGAGGGCGCGTCCATCGACAAGCAGGACCACGAGGCGGACCCCTGCGGCCAGATCGGCGAGACCGCCGCCTTCGACCGGGCCGTCAAGGTCGCCCGCGACTACGCCGCCCGGCACCCCGACACCCTCGTGATCGCCACCGCTGACCACGGCCACAGCAGCCAGATCGTGCCCCTGGACGCCAGTCCGCCCAGCCTGTGGTCGACGCTGATCACGGACGAGGGCGGCCGGCTCAAGGTCGCCTACGCCACCACCGACGCCCCGGAGGACGGCCAGGAGCACACCGGCACCCAGGTCCGCATCGCCGCCCAGGGCCCGTACGCCGAGCGGGTCGAAGGGGTCACCGACCAGACGGAGCTGTTCACGACGATCACCAAGGCGCTCGGGCTGCGCTGA	MTRPRSPHRPARRRVSRAAVALLVAAAVPTLTSATADGTGGGSPRAARNVILLIGDGMGDSEITLARDYTVGAGGRLNLDRFPSTGTYTTYSVDSRGRPDYVTDSAASASAWSTGHKTVNGRISKSPGTDTALPTILELARAKGLATGSVTTAELTDATPAAMAAHATDRDCQGPADMAACPRDTIARGGPGSIAEQSVRLRPDVLLGGGRQRFDQKITQGPYRGMTVTQQAEKLGYRVVTDAGGLRTAAPGQPLLGLFAPGAIPVEWTGRPAAAGGTAPQRCVTANPARPAGTPSLEQQTAKALELLEARARAGGGADRGFFLQVEGASIDKQDHEADPCGQIGETAAFDRAVKVARDYAARHPDTLVIATADHGHSSQIVPLDASPPSLWSTLITDEGGRLKVAYATTDAPEDGQEHTGTQVRIAAQGPYAERVEGVTDQTELFTTITKALGLR	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAAHLFLTTIGGPKELTAFLHNMGDHVTRLDCWGPKLTEAIPHDERDTTMPAAVANTLRKLLTGELLTLASRQQLIDWMEADKVAGPILRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	159.44	gnl|BL_ORD_ID|1265|hsp_num:0	1380			279	591	ampicillin
BGC0000708.1|Lividomycin_20 # 26567 # 27022 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0000708.1|Lividomycin_20 	26567	27022	+	Loose	350	24.2534	AAC(2')-Id	36.96	3002526	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GTGCGCAAGTTCGACCAGCGGCTCAACGAACTGATCGCGGCCCTGCACCCCGACGAACGCAAGCGCCCCGGATACGCCCGGCTCGCCAAGGAGATCAGCGAGTCCACGGGAGGCACGATCTCCGGCACGTACCTGTGGGAACTGGCCACGGGCAAGAAGCGCAACGTCACCCTGGAACAGCTCGACGTCCTCGCCGAGTACTTCGGCGTACCACCCGAGTACTTCCTCAGCGAAGAGGTGGCCGAGCGCGTCAGCTCCCAGCTCAAGCTGGCCACCGCGCTGCGCGACGCCCGGGTCCGCAACCTCGCCCTGCGGGCCGACGGCCTGTCGCCGGCCACCCTGGACGCGCTGCTGGTCATGGTGAACGAAGCCCGCAAGGTGCAGAACCTGGCGTCCGTCGACGACCTCGCGGACGGCAGTGGGACCGCGAACGGCAGCGTGGCCGGGAGTGGTTGA	MRKFDQRLNELIAALHPDERKRPGYARLAKEISESTGGTISGTYLWELATGKKRNVTLEQLDVLAEYFGVPPEYFLSEEVAERVSSQLKLATALRDARVRNLALRADGLSPATLDALLVMVNEARKVQNLASVDDLADGSGTANGSVAGSG	MLTQHVSEARTRGAIHTARLIHTSDLDQETRDGARRMVIEAFRDPSGDSDFTDDFTDDDWDHALGGMHALISHHGALIAHGAVVQRRLMYRGPDGRGHALRCGYVEAVAVREDRRGDGLGTAVLDALEQVIRGAYQIGALSASDIARPMYIARGWLSWEGPTSVLTPTEGIVRTPEDDRSLFVLPVDLPDGLELDTAREITCDWRSGDPW	71.90	gnl|BL_ORD_ID|1297|hsp_num:0	1415			294	432	dibekacin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; gentamicin
BGC0000708.1|Lividomycin_21 # 27421 # 27933 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000708.1|Lividomycin_21 	27421	27933	+	Loose	700	24.2534	OCH-4	32.35	3002517	protein homolog model	n/a	n/a	monobactam; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	OCH beta-lactamase	ATGCCATACCGGTATGTCCAACTGCGCCGTCGGTGCCAGCAGAAGCTGGACCAGTTCGACCTGCCCCGCCCCTTCTCGATGGACGCCTTATGCGAGAGCGTCTCCCGGCAGCGCGGCCGTCCGCTGTACCTGCACCCGCTGCCGGACCAGGCCGCCACGGCCGGAGCCTGCGGCCTGTGGCTCGCGACCGCCACGGACGACCACATCTTCTTCGAACAGCACACGGTACGGCTCCACCAGGAGCACATCGTGCTGCACGAGATCGGGCACATGCTGTTCGACCATCACGCCGTGGACGCCAGGACCGGCTCCGCGATCCTGCCCGACCTCTTCCTCGACCTCGACCCGCGACTGGTCCGGCGCCTGCTCGCCCGCACCAACTACAGCACGCGCCAGGAGCAGGAGGCCGAGATGCTCGCCAGCCTGATACGCGCCGGGGACCACGGACCCGGCGGGGAGCGGGACGGGGTGCTGCGCAATCTCGGCGCCGCCCTCGGTGTGAGCGGCCGGTGA	MPYRYVQLRRRCQQKLDQFDLPRPFSMDALCESVSRQRGRPLYLHPLPDQAATAGACGLWLATATDDHIFFEQHTVRLHQEHIVLHEIGHMLFDHHAVDARTGSAILPDLFLDLDPRLVRRLLARTNYSTRQEQEAEMLASLIRAGDHGPGGERDGVLRNLGAALGVSGR	MRKSTTLLIGFLTTAAIIPNNGALATSKANDGDLRRIVDETVRPLMAEQKIPGMAVAITIDGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAPELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPSIGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPASQMKNYAYGYSKANKPIRVSGGALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFYNYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKIGIVLLANRNYPIDERVKAAYRILQALDNKQ	43.59	gnl|BL_ORD_ID|711|hsp_num:0	773			966	1068	
BGC0000708.1|Lividomycin_22 # 27930 # 29153 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.742	BGC0000708.1|Lividomycin_22 	27930	29153	+	Loose	550	27.335	LRA-19	36.36	3002513	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGACCGACGCAGTGGCGGTACTGGGCCCCTGGTATCTGGTCGCCGGTGTCAGCTGCCTGTGGAGCGCGGTACTGCTGCGCTGCCGCTCGGCCGTACGCTCTCCCCACCAGCGCGGCCTGTGGCTGGCCGTCGCGACCGCCGCCGTGGCGATGACCATGGACCTGCCCGCCGTCGACTCCTTCCTCCAGGCCCGCACGGGCCTCGGCCACCTGCACCACCTGGCGCGGGACCTGTTCGGGCTGCTGTCCGCCGGCGCCGTCCTGCGCTTCGTGGCGGCCTCCGGCAACTGCCGGTACGGCAGGGGGGTGTACGTGGCGGTCGCCGCCTTGACGGCGGCCCTGATCACCCTGGACCTGCTCGCCGCCCCGCACGGCGAACACACCGCCCACGGCGCACGGTCGACGACCGAGACCACCGCGTACTGGCTGATCCTCATAGCGATGCACCTCTTCGCCGGAGCGATGTGCTTCCGGCTGTGCTGGCGCTACGCCGGCCGCGCCGACAGCCGTTCGCTCCGGCTGGGGCTGTGGCTGTTCGGCTGGGGCACCGCCTCCGCCGGGCTCTTCTGGGCGGGCCACTTCCTCCTGTTCTGTGCCGAGGCCCAGGAGCCGGTGCCCTGGCTGCGGCTGCTGATGGTCGTACAGGGCGTGCTGTGGGCGGCGGCCATCCTCCTCCCCGTCGCGGTCGCCTCCGCCGGCGCCGTCGGACACATCGGGACGGTGTGGCGGCTGTGGCCGCTGTGGCGGCACCTGGTGGACGCCGCACCGCACGTCGCCCTGATGAAGCCCCGCAACCGCCTGCTGGAACTGCTGCGCCCCCGGCACTCCTGGCGCCTCCTCGGCTACCGCAAGGTCATCGAGACCCGGGACGCCATCCTCGGCCTGCGCGGCTACGCCGACCCCACCGTCCCCGGCCTCGCCCGCCGCTACACGGCCACCGCGGGCCTGGCCGACGGGGAGGCGGACCTGGTGGCCCTGGCCTGCGAGCTGAGCGAGGCCCGCCGCGCCAAACTCGCCGGACTGCCCCGGCGGACGGCTCCGGACGGCTGGTTCGGCGGGGACAGCCGCGACCTCGACGACGAGACGGCCTTCCTCCTCCGGCTCTCCCGTGCCTACCACTCGCCCCACGTACGGGAGTTCCACCTCTACATGGCCGTCCAGGACGCGGCGGGCCACGCGGCGCAGGACGGCACCGGACGCCCGCCGACCCGCTCCGCTTCCTGA	MTDAVAVLGPWYLVAGVSCLWSAVLLRCRSAVRSPHQRGLWLAVATAAVAMTMDLPAVDSFLQARTGLGHLHHLARDLFGLLSAGAVLRFVAASGNCRYGRGVYVAVAALTAALITLDLLAAPHGEHTAHGARSTTETTAYWLILIAMHLFAGAMCFRLCWRYAGRADSRSLRLGLWLFGWGTASAGLFWAGHFLLFCAEAQEPVPWLRLLMVVQGVLWAAAILLPVAVASAGAVGHIGTVWRLWPLWRHLVDAAPHVALMKPRNRLLELLRPRHSWRLLGYRKVIETRDAILGLRGYADPTVPGLARRYTATAGLADGEADLVALACELSEARRAKLAGLPRRTAPDGWFGGDSRDLDDETAFLLRLSRAYHSPHVREFHLYMAVQDAAGHAAQDGTGRPPTRSAS	MNSEMSQTSFKIRILVTCLLSIAQLTMAQQVQVTEPPITNQDWVKPYPPFRIVGNLYYVGTYDLACYLIVTPQGNILINTGLASSAPMIEASIKALGFKFSDTKILLTTQAHYDHVGAMAAIKKSTNAQLMIDEKDSPVMADGGSSDYELFGSTGSTYEPVKADRLLKNGDKITLGGTTLVMLHHPGHTKGSCSFLFDVKDESKSYKVLIANMPSIITSKKFSDIPTYPGIAEDYTYTFDAMKKVHFDIWLSSHASQFGMHSKHKPGEAYNPGVFIDRAGYDKAVGDLEDKFSKKKQADK	135.67	gnl|BL_ORD_ID|1339|hsp_num:0	1462			615	714	
BGC0000708.1|Lividomycin_23 # 29241 # 33323 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=CGCACG;rbs_spacer=14bp;gc_cont=0.746	BGC0000708.1|Lividomycin_23 	29241	33323	-	Loose	500	28.4906	OXA-18	34.69	3001413	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTATCGCCAGACCATGGACATTGATTCCGAGTCCACCGCGAACAGCTCCGCCCCGGCCACCGGGACCGGGGCGGCCACGGCCCTCGACCACACCGGGAGCCCGGCCCCCGGCCGGGACCGCTCCCCGGACGACCGGCACGACGGACACCGCGCTGCCGCCCACCCGGACCGCCGGGCCCTGGAAGCGCGTTACGGCACCAAGTGCGCCCGGCTGCTCCTGCTGGCCGCCGATCCCGCCTACCGCCCGGTGGCCCTCCCCGTTTTACCGCTGGACGACGCGGAGGCCCGCGCCTTCGCCTCCCGTAACGGGACACGCCTCTCGCCCGACGGCGAGCGGGACCACACCGCCCTGGTGTCCGCCTACGGCGCGTACCTGCGGGAACAACGCCCCGGCCTGGCCGCGGAGGTACGGGTGGAGTGCGGCCCCGCGCCCTGGATCGTGCGCAGTTCCGGCGCCGAGGACACCGCGGTGAACGTCAACGCGGGCGGCTACGACAGCGTCGTGTGCCGGAGCGAGGCGGAGCTGTACGACACCGTCGCCACCGTCGTGTGGAGCGGGTGCACCGAGCGGGCGGTGGCCCAGCAGCGGCTCGCCGACCCGGACCACCGGCCCGGCCCCATCCCGGTCTTCGTCCAGCCCCTGATCGACGCGGCCTACGAGGAGGGCGCGCCGCCCGCGGAGGACGAACTGCCCCTGCTCGACGAGGACACGGTCACGGACATCGCCGGCTGGCTGCGCCGGCTGCACCGCACCTTCGGTGAGGCGCGGCTGGACTGCGAGTGGGTGGTGGAGACCGATGCCGGGCCGGTCTCCGTGACGAGCCTGACGGAGGCCCGTGACGGCCGTACCGAGGCGGCCGGAGGGACGGCCGGAGCGGCTGCCGGAGAAGCGGCCGGAGGGACTGCCGGAGAAACGGATGCCCCCGGGAGCCCCGCCGGGCAGCTCGCGCTCGGTTTCGGGTTCGCCGCCGCGCAGCGGGTGGACGCCCGGGGCAACAGTGTCGCCTGGCTGGCCGGTGACGCCGCCGGAAGCGTGCTGTGGCAGGGCGCGATGCTGCGGCAGGTACGTGCCTCGGCGCTGCGGCTGGTGCAGGTCAGGCCGGCCACCGCGTTCGATCCGGAACCGCGGGTGGACGTGCTCACCGAGGACTCCCACCGCGCCTGGGAGGAGACCTGCTCCGCCCTGCCCGCCGAGTTCCTGGTCCCGCCCCGGCGGATCGCCGCCACGGCCTTCCTCGCGGCCACCACGCTGGACGACGCGTGGGCCCGCTACCTGGGCCTGGACGGTCCGCAGCGCGAGCGTGTCGGGCATGTCTTCGTCGAACGCGGCAGTCCCGCCGAACACGCGGGGGTGATGTTCCGGCAGGCGGGCGTCGCGGTGCTGCGCGCACGGCTGGACGAGCTGCCGGGCTGGGCCTCGTACGCCCTCGCCGACCCGTGGAGCCGCGTCTGCTTCTTCGGCGACGGCGAGCCGCCCCTCCTGCGCACCGTCCCGCGCCGGGTCGCGGACGTGCCCGCCGACGCCCGGCTGCTGTTCTCCCCCGACCGGTGTGCCGACGCGGCCGGCGCGGTACGCGAGGCTGGCCGGGCGCCCACCGTGGAGTCGATGCCGGGTGCCGACGCCGTACGGGCCCTGCCCGGTCTGCCGCCCGTCGTCAAGGACCGGGTGCTGGAGCAGAGCCTGCTGCCGTCGTCCGCCTCGTTCCGTCGGGTCCGCGACCACGGCCACGACCGCGTGGAGTCCCCCGCGTTCCTGGCCCAGCTCGCCATCCGTCTGGCCGGTGACGGTCAGGAGACGGCAGCCCGCGCGCTGCTCGACGGGCTTCCCGAAGCTGCGCGCGCTTGTATGCGTGCCGTGCTCGCCGCCCAGGGGGCCCTGTCCCCGGCCGAGGCGTTTCCCGCCTCCACCGCCGCCCTGGCGCACGGGAGCGCGGACGTCCCGGGTGTGGCCACCGTCGCGGCCTGCGCCGATCTGCGTCCTGCCGTGGCGCTGGCCGAACTCGACGACGACCCGCGGGTGACGGCCACGGTACGTGCCGAGGCCGTACGGATGGGCGCCGCCCTCGTCACGGCCGGAGCGCCCCGCGCGGCGTTCCGCCTGCTGCGCGTCGTGCGGCGCATGACGGACGACATGGACGCGCTGTGCGTCTACACCCCCGAGGAACGGGAGCGGGTGCTGCTGGACACCCTCGCTCTGCTGCCGCCGGACGCGCCCGGCCGCGTCGAGCGGTGGTGCGCCCTGCTGCTGTCCTCCTCGATGCCGCCGGGCGAGGCGCCGCGTCTGCTCGGCCTGGCCGCCGGGGAGGACGGCTTCGCGGAGGGCTATCTGCGGCTGAAGGAGTGCGAGAGCACGTTCACGGCAGCGGCCGGTCTGGGCGAGGCCACCGAACGGGCCCGTGAACTCAACGACGCCTACCGGGCCTTCGTCGCCGGCGACCGGTGGACGCCCGGGGCCCGGCCGTTGCTGGACCTCGTCCACTCCGACCTGGTGGAGGTCTACGACGCGGCGCTGAAGAAGATCCTGCTCCAGCTCGTGGACCGGCCCGGGCCGTTCCTGTACCGGCTGTACCTGGACGTGATGTCCGCCTGGCTGGACGCGGCGGGCGCGGGCGGTCTCGCCGCGGACGAGCGGCGCGCCGCCGCGGTCTTCCGGGAGTGGATCGCGAAGTGGCGCGCCGGAGAGCCGCACGGCGACTACACGATCGAGCACTTCACCCAGCCCAGGCTGGTGATCGACCTCGCGGCGGCCGGTCAGGGCGACACGGTCGCGCCGGACAATCCGCACCAGCTCCACAACCTCCTGCACCAGTGGCTGCTGTCCCGCCTGGAGCGTTTCCCCGTCGAGCAGGCCCCCGGCCGTCTCGTCGAGCTGCACCGGTTCTGTGACCGCTTCTGCCGGGGCGGCAACAAGCTGCTGCGCTTCACACGGGACAGCTTCGAGCTGGAGATCCCCCTGTCGATCCACAAGGCGAGCCTGCTGTTCCGGCCGGACCGGATCGAGGTCGAGTGGAGCGAGCAGCCGGGGGTGGAAGAGGAGGAGACCGGGCGGCTGCTGGCGTTCACGGTGCTGCTGCGCCGCTTCGGCGACTGGTTCCCCGACCTGGTCCTGCGCGCCGACAAGCTGCTGCTGGCGGGGACCTGGACGCTGCGCATCGAGGTGCGTCCGAGCGGCGCCGGCCGCTTCACCTACCCGCGGATGCGGCTGGCCCTGGAGCTGCTGCGCACGATGCTCGACGCCTCGTTCGACTTCTCCTACGTGGAGAACGAGGAAGTCGCCGGGATCGACGAGGCGTTCGCCGACGACGTGTGGAAGGAGTACTTCACCGGTCTGGTCGCCTACCGCAGGGAGCTGGACGACTCGGACCAGTACGAGGCCGTGGAGTCCCTGCCGCTGGGCACCGCGATGGCCGCCGTCTGCCTGGACGGGGTGACCCGTACGGAGGTGGCACGCGCGGTCCGCGCGGGAGGCGCCGCCACGTTCGCCCGTATGGACGCCCTGTGGGAGGAGTTGGCCGGGGAACGGACGCCGGACGCCTGGAACGCTCTGTTCGTCCGGGCCCAGCAGCTCACCCTGACGGCCGCCGCGCTGTGGCCCGAGGAGTCCGCCGCCGTACTGCGGGAGGGCGGGCGGCCGTGGGCGGACCTGCTGGCGACGAGCCTGCTGCGCCGCCGGGACGTGCGCGACCGCCTGGCCGCCGGGTGCGACGACAAGGCCGCCGCGTCGCTCACGGGACTGGCGGGGGCTCTGCTGCGGCACACGCCCGCCGCCCTGCTGCGGCCGGACGCCCCGGACAGCGTGGCCGCGGTCGCGGCGGAGCTGGCGGACCGGCCCAGGGTGTTCCGCCGGTGCAAGCAGTACCTGGTGCACCGGTACGCCGACATCCTCGCCACGGGTGTCCTGGACCGGCTCGTCGCGGACCTGGAGACCGTCCCCGAGGGGTTCTCCGGGGTCCAGGAGGAGGCCATTTCCGCGGCTCTGGGCCGGGTGGACGGCGGGCCGCGCTTCCGGGCCCCGGTCCGCTCCAAGGTGGACGAGGCGCATCCGCTGTTCCGCGCGGCGCGGGCGCGTTCCGCGGGCTGA	MYRQTMDIDSESTANSSAPATGTGAATALDHTGSPAPGRDRSPDDRHDGHRAAAHPDRRALEARYGTKCARLLLLAADPAYRPVALPVLPLDDAEARAFASRNGTRLSPDGERDHTALVSAYGAYLREQRPGLAAEVRVECGPAPWIVRSSGAEDTAVNVNAGGYDSVVCRSEAELYDTVATVVWSGCTERAVAQQRLADPDHRPGPIPVFVQPLIDAAYEEGAPPAEDELPLLDEDTVTDIAGWLRRLHRTFGEARLDCEWVVETDAGPVSVTSLTEARDGRTEAAGGTAGAAAGEAAGGTAGETDAPGSPAGQLALGFGFAAAQRVDARGNSVAWLAGDAAGSVLWQGAMLRQVRASALRLVQVRPATAFDPEPRVDVLTEDSHRAWEETCSALPAEFLVPPRRIAATAFLAATTLDDAWARYLGLDGPQRERVGHVFVERGSPAEHAGVMFRQAGVAVLRARLDELPGWASYALADPWSRVCFFGDGEPPLLRTVPRRVADVPADARLLFSPDRCADAAGAVREAGRAPTVESMPGADAVRALPGLPPVVKDRVLEQSLLPSSASFRRVRDHGHDRVESPAFLAQLAIRLAGDGQETAARALLDGLPEAARACMRAVLAAQGALSPAEAFPASTAALAHGSADVPGVATVAACADLRPAVALAELDDDPRVTATVRAEAVRMGAALVTAGAPRAAFRLLRVVRRMTDDMDALCVYTPEERERVLLDTLALLPPDAPGRVERWCALLLSSSMPPGEAPRLLGLAAGEDGFAEGYLRLKECESTFTAAAGLGEATERARELNDAYRAFVAGDRWTPGARPLLDLVHSDLVEVYDAALKKILLQLVDRPGPFLYRLYLDVMSAWLDAAGAGGLAADERRAAAVFREWIAKWRAGEPHGDYTIEHFTQPRLVIDLAAAGQGDTVAPDNPHQLHNLLHQWLLSRLERFPVEQAPGRLVELHRFCDRFCRGGNKLLRFTRDSFELEIPLSIHKASLLFRPDRIEVEWSEQPGVEEEETGRLLAFTVLLRRFGDWFPDLVLRADKLLLAGTWTLRIEVRPSGAGRFTYPRMRLALELLRTMLDASFDFSYVENEEVAGIDEAFADDVWKEYFTGLVAYRRELDDSDQYEAVESLPLGTAMAAVCLDGVTRTEVARAVRAGGAATFARMDALWEELAGERTPDAWNALFVRAQQLTLTAAALWPEESAAVLREGGRPWADLLATSLLRRRDVRDRLAAGCDDKAAASLTGLAGALLRHTPAALLRPDAPDSVAAVAAELADRPRVFRRCKQYLVHRYADILATGVLDRLVADLETVPEGFSGVQEEAISAALGRVDGGPRFRAPVRSKVDEAHPLFRAARARSAG	MQRSLSMSGKRHFIFAVSFVISTVCLTFSPANAAQKLSCTLVIDEASGDLLHREGSCDKAFAPMSTFKLPLAIMGYDADILLDATTPRWDYKPEFNGYKSQQKPTDPTIWLKDSIVWYSQELTRRLGESRFSDYVQRFDYGNKDVSGDPGKHNGLTHAWLASSLKISPEEQVRFLRRFLRGELPVSEDALEMTKAVVPHFEAGDWDVQGKTGTGSLSDAKGGKAPIGWFIGWATRDDRRVVFARLTVGARKGEQPAGPAARDEFLNTLPALSENF	494.55	gnl|BL_ORD_ID|927|hsp_num:0	1003			420	543	cloxacillin; oxacillin; cefalotin
BGC0000708.1|Lividomycin_24 # 34028 # 34270 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000708.1|Lividomycin_24 	34028	34270	-	Loose	525	25.409	EFM-1	32.43	3006884	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EFM beta-lactamase	ATGACGCTCATGCTCGTACTGAAGTGCCTGAGCGACCAGACCGGCGACTCCGCCGAGGAGATCGCCGAGGCCGGGTACGTCGAAGGCGACGACCGTGACTACGTCGAGGCCGTGAACCGGCTGGAGTCCTACTTCGACTGCACCCTCGACCTGCTCGGCGCCGACGGCCGCCGCATCGTGGTCGAGGACGTGGTGGCCCGTATACCCGCCGGTGCCGGTGTCCTGGCGGGCGGCCGTGACTGA	MTLMLVLKCLSDQTGDSAEEIAEAGYVEGDDRDYVEAVNRLESYFDCTLDLLGADGRRIVVEDVVARIPAGAGVLAGGRD	MSARCLPALTLPLALAACAPPIQTPDPLPPREIVTPQQWAQQCTDWDEWDKPAPPYRIHGSTYYVGTCGIAAILVAGDGGHILIDSGTEAGADVVLDNVGKLGFRPNEIASLLHSHEHFDHTGGHALVRRESGAHVVASPQAAPVLRTGEDDPADPQHGLHDAMEPVPVDVIVRDGETVRSESATLTAIATPGHTPGALSWAWQSCDEAGDCLSIVYADSLSPISRKGYRFGDHPEYLEGFRAGLEKLRAVDCDILLTPHPSASDMVTRAAAGSMVGGMSCVDYADAVEARLDARLVEEAGD	26.49	gnl|BL_ORD_ID|3529|hsp_num:0	4598			633	834	
BGC0000708.1|Lividomycin_25 # 34474 # 34689 # -1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000708.1|Lividomycin_25 	34474	34689	-	Loose	2090	22.7126	smeB	55.0	3003052	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGGTCCGCCCAAGAGGGACCTTGCCGGAGGGTCCCGGAAGGGCAGCCTCTGATCGGCCCGCGATCGGGCGAAGCCTCGCACACACTCCCGCGTCTGGCGAGAGCGCCACGCTCTCCCGAGCGCGCGCGGCCCGTCACGGACGCACGGCGTGTCCCCCGCCGGTACGCCCCGCAGACCAATTCGGGCCGGGAAAAAGAGAATTCCTGGCTATGA	MRSAQEGPCRRVPEGQPLIGPRSGEASHTLPRLARAPRSPERARPVTDARRVPRRYAPQTNSGREKENSWL	MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENAVTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQAVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQEYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRLHTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAIAVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQNWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVMTFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMILSVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVDRFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMDRLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMASVPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRYASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAEARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSGEAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVPFAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKSTREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGMFFVPLFYLLVRRLFPGRAPADATVPETSP	6.77	gnl|BL_ORD_ID|1813|hsp_num:0	1960			2490	2550	
BGC0000708.1|Lividomycin_26 # 34964 # 36256 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=ACCAC;rbs_spacer=13bp;gc_cont=0.711	BGC0000708.1|Lividomycin_26 	34964	36256	+	Loose	500	29.6462	ErmD	32.14	3000495	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGTCACTCCCACAATCAGCCACCACTCCGCATGAGGGGCGGTGGGCCCGGCTGCTGCCCATCGCCTCGGCGGCGGTGCTGGTCGCCGCTGCCGCCTACGCCCTGGGCTGGGCACTGGTCCCGGGCGTCGGCACCGACGACCCCCTCCAGTACGACCTGGACATCTACCGTTCGGCGATCGCCGAACGCGCCTCGGGACACTCGCTGTACGACATCGCCACCGGTGAGGGCGACGTCTTCAACTACCCGCCGTTCGCCGCACTGTTCCTGTGGCCCCTGCACTGGCTCGGCGACCGCGCCGCCGCCCTCGTCTGGACGGCCCTCACACTGGCGGCGACCATCCTGGCGGTCGTCCTCCTGTACCAGGCCGCACGCGCGCACCGGCAGCGGCGGAACTTCCCCCTGTTCGCGATCGTCCTGGCAGCGGTCCTGGTGAGCTCCGCCCACCTCGCCACCCAGCTCTGGGGCCAACTGGGCGCGCTGCTCACCGTTCTGGCCCTGGCCGACGCGCTGGGGCGCCTGCCGAGGCCCTTCGGCGGTGCGCTCATCGGACTGGCGGCGGCCGTCAAACTCGCCCCGCTGATGTTCATCCCCTACTTCCTGCTCACCCGGCGGTACCGCGAAGCGGCCACGGCCTCGGCGGTGTTCACCGGGGCGGCCCTGCTGGCGTGGGTGGTGTTCCCGTCCGACTCCGCGCGCTTCTGGCTCTCCGAGACGTTCCGGATGCGCGAACGTGTGTGGGACATCGCCGACCCCGCCAACCAGTCGCTGTACTCCTTCGTCCTGCGCTGCGGCCTCGGTCCGACGGCGACCTCCGTCGTCTTCGCGGCGGCGGCACTCGCGGTGCTCGCCGTCTGGGCGTTCTGGGTCCGCCGTCTCCGTACCCGTGACCCGGTCCTCGCCGTCCTCGTCACCGGATGCGTGTGGGTCCTGCTGGAACCGGTCACCTGGGTGCACCACCTGTACTGGCCCGTGCTGGCCGGAGCGTGGCTGGTGCTGCGGTACCGAGGTCTGTGGCGCCGGGGGGCCGGAGCGGTGGTACTGCTGCTGATGCTGCGGCCGATGGACTGGGGCGACCGGGTGCCGAGCCAGCACGGCGTGTGGCCGATGCTGTCCGTGAACTCCTGGCTCTTCGTCGTGATCGCGACGGTGACGGTCCTGCCGGCGCTCTCTCCGCCGTCCCGGGAATGCGACGATGCCTTCCGCGTCAAGTCCGCCAATTCGTGGCCCACTTCACGTTTACCGGGCCCGGCCGGTGTCCCGCGAGGAGAGGCCCCGCCGAAAACGAAGTAA	MSLPQSATTPHEGRWARLLPIASAAVLVAAAAYALGWALVPGVGTDDPLQYDLDIYRSAIAERASGHSLYDIATGEGDVFNYPPFAALFLWPLHWLGDRAAALVWTALTLAATILAVVLLYQAARAHRQRRNFPLFAIVLAAVLVSSAHLATQLWGQLGALLTVLALADALGRLPRPFGGALIGLAAAVKLAPLMFIPYFLLTRRYREAATASAVFTGAALLAWVVFPSDSARFWLSETFRMRERVWDIADPANQSLYSFVLRCGLGPTATSVVFAAAALAVLAVWAFWVRRLRTRDPVLAVLVTGCVWVLLEPVTWVHHLYWPVLAGAWLVLRYRGLWRRGAGAVVLLLMLRPMDWGDRVPSQHGVWPMLSVNSWLFVVIATVTVLPALSPPSRECDDAFRVKSANSWPTSRLPGPAGVPRGEAPPKTK	MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTTVLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAITTPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHFSPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHLRKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI	149.83	gnl|BL_ORD_ID|1022|hsp_num:0	1117			48	216	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
